Literature DB >> 29101127

Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients.

Kalliopi Sofou1, Irenaeus F M de Coo2, Elsebet Ostergaard3, Pirjo Isohanni4,5, Karin Naess6, Linda De Meirleir7, Charalampos Tzoulis8,9, Johanna Uusimaa10,11, Tuula Lönnqvist4, Laurence Albert Bindoff8,9, Már Tulinius1, Niklas Darin1.   

Abstract

BACKGROUND: Leigh syndrome is a phenotypically and genetically heterogeneous mitochondrial disorder. While some genetic defects are associated with well-described phenotypes, phenotype-genotype correlations in Leigh syndrome are not fully explored.
OBJECTIVE: We aimed to identify phenotype-genotype correlations in Leigh syndrome in a large cohort of systematically evaluated patients.
METHODS: We studied 96 patients with genetically confirmed Leigh syndrome diagnosed and followed in eight European centres specialising in mitochondrial diseases.
RESULTS: We found that ataxia, ophthalmoplegia and cardiomyopathy were more prevalent among patients with mitochondrial DNA defects. Patients with mutations in MT-ND and NDUF genes with complex I deficiency shared common phenotypic features, such as early development of central nervous system disease, followed by high occurrence of cardiac and ocular manifestations. The cerebral cortex was affected in patients with NDUF mutations significantly more often than the rest of the cohort. Patients with the m.8993T>G mutation in MT-ATP6 gene had more severe clinical and radiological manifestations and poorer disease outcome compared with patients with the m.8993T>C mutation.
CONCLUSION: Our study provides new insights into phenotype-genotype correlations in Leigh syndrome and particularly in patients with complex I deficiency and with defects in the mitochondrial ATP synthase. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Leigh syndrome; MRI; complex I; genetic; mitochondrial DNA

Mesh:

Substances:

Year:  2017        PMID: 29101127     DOI: 10.1136/jmedgenet-2017-104891

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  14 in total

1.  Homoplasmy of the m. 8993 T>G variant in a patient without MRI findings of Leigh syndrome, ataxia or retinal abnormalities.

Authors:  Russell P Saneto; Kristina E Patrick; Francisco A Perez
Journal:  Mitochondrion       Date:  2021-04-22       Impact factor: 4.534

2.  DNAJC30 defect: a frequent cause of recessive Leber hereditary optic neuropathy and Leigh syndrome.

Authors:  Sarah L Stenton; Marketa Tesarova; Natalia L Sheremet; Claudia B Catarino; Valerio Carelli; Elżbieta Ciara; Kathryn Curry; Martin Engvall; Leah R Fleming; Peter Freisinger; Katarzyna Iwanicka-Pronicka; Elżbieta Jurkiewicz; Thomas Klopstock; Mary K Koenig; Hana Kolářová; Bohdan Kousal; Tatiana Krylova; Chiara La Morgia; Lenka Nosková; Dorota Piekutowska-Abramczuk; Sam N Russo; Viktor Stránecký; Iveta Tóthová; Frank Träisk; Holger Prokisch
Journal:  Brain       Date:  2022-06-03       Impact factor: 15.255

3.  Vaccination triggering onset of m.8993T > G associated Leigh syndrome.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2018-04-25

4.  Clinical, Neuroimaging, and Pathological Analyses of 13 Chinese Leigh Syndrome Patients with Mitochondrial DNA Mutations.

Authors:  Xiao-Lin Yu; Chuan-Zhu Yan; Kun-Qian Ji; Peng-Fei Lin; Xue-Bi Xu; Ting-Jun Dai; Wei Li; Yu-Ying Zhao
Journal:  Chin Med J (Engl)       Date:  2018-11-20       Impact factor: 2.628

5.  Leigh syndrome caused by mutations in MTFMT is associated with a better prognosis.

Authors:  Hannah Hayhurst; Irenaeus F M de Coo; Dorota Piekutowska-Abramczuk; Charlotte L Alston; Sunil Sharma; Kyle Thompson; Rocio Rius; Langping He; Sila Hopton; Rafal Ploski; Elzbieta Ciara; Nicole J Lake; Alison G Compton; Martin B Delatycki; Aad Verrips; Penelope E Bonnen; Simon A Jones; Andrew A Morris; David Shakespeare; John Christodoulou; Dorota Wesol-Kucharska; Dariusz Rokicki; Hubert J M Smeets; Ewa Pronicka; David R Thorburn; Grainne S Gorman; Robert McFarland; Robert W Taylor; Yi Shiau Ng
Journal:  Ann Clin Transl Neurol       Date:  2019-02-17       Impact factor: 4.511

6.  Bilateral striatal necrosis due to homoplasmic mitochondrial 3697G>A mutation presents with incomplete penetrance and sex bias.

Authors:  Shanshan Zhong; Shumeng Wen; Yusen Qiu; Yanyan Yu; Ling Xin; Yang He; Xuguang Gao; Hezhi Fang; Daojun Hong; Jun Zhang
Journal:  Mol Genet Genomic Med       Date:  2019-01-08       Impact factor: 2.183

7.  Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration.

Authors:  Claudia Stendel; Christiane Neuhofer; Elisa Floride; Shi Yuqing; Rebecca D Ganetzky; Joohyun Park; Peter Freisinger; Cornelia Kornblum; Stephanie Kleinle; Ludger Schöls; Felix Distelmaier; Georg M Stettner; Boriana Büchner; Marni J Falk; Johannes A Mayr; Matthis Synofzik; Angela Abicht; Tobias B Haack; Holger Prokisch; Saskia B Wortmann; Kei Murayama; Fang Fang; Thomas Klopstock
Journal:  Neurol Genet       Date:  2020-01-13

Review 8.  Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells.

Authors:  Mario G Pavez-Giani; Lukas Cyganek
Journal:  Front Cell Dev Biol       Date:  2022-01-10

Review 9.  Strategies for mitochondrial gene editing.

Authors:  Xingbo Yang; Jiacheng Jiang; Zongyu Li; Jiayi Liang; Yaozu Xiang
Journal:  Comput Struct Biotechnol J       Date:  2021-06-04       Impact factor: 7.271

Review 10.  Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype.

Authors:  Inn-Chi Lee; Kuo-Liang Chiang
Journal:  Antioxidants (Basel)       Date:  2021-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.